Outcome After Azacitidine Treatment in Patients with High-Risk Myeolodysplastic Syndrome, Chronic Myelomonocytic Leukemia Type 2 and Acute Myeloid Leukemia – A Single Center Experience (Preliminary Data)
Varbanova, V., Anastasova-Postadzhiyan, A., Nedeva, A., Nikolov, I., Kindekov, I., Kuyumdzhieva, Y., Petkova, N., Vikentieva, E., Lubomir, M., Raynov, J.
Continued Professional Education of Bulgarian Pharmacists: Second Registration Period
Petrova, G., Nikolov, I., Ivanova, Z., Decheva, Tz., Draganov, G., Naydenov, T., Stoimenova, A.